POST Online Media Lite Edition


Purdue Pharma to invest $59 million, create 100 jobs

Staff writer |
Purdue Pharma Manufacturing will build a new facility in Durham County, create 100 new jobs, and invest $59 million over the next three years in Durham.

Article continues below

"North Carolina is recognized around the world for our bioscience and cutting-edge pharmaceutical companies. We're committed to helping companies like Purdue Pharma grow their business and get more products to the global marketplace," Governor Pat McCrory.

Purdue is engaged in the research, development, production, and marketing of prescription and over-the-counter medicines and health care products. Purdue is an industry leader in pain medication research, and makes several important medications used to treat pain.

"Companies know North Carolina is home to some of the most talented pharmaceutical professionals in the world. We are delighted to have Purdue reinvest in North Carolina and wish them continued success in Durham," said Sharon Decker, North Carolina Secretary of Commerce.

The new Durham facility represents the second major investment Purdue has made in North Carolina. In 2000, Purdue opened a state-of-the-art manufacturing facility in Wilson, bringing approximately 180 new engineering, scientific and technical jobs to North Carolina. The Wilson operation pioneered the use of product tracking technology and anti-counterfeit packaging to enable authentication and traceability of products from its warehouse all the way to the pharmacy shelf.

Salaries will vary by job function, but the average annual wage for the new jobs will be $70,199 plus benefits. The Durham County average annual wage is $66,602.

The project was made possible in part by a performance-based grant from the One North Carolina Fund of up to $300,000. The One NC Fund provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs in the state.

Companies receive no money up front and must meet job creation and investment performance standards to qualify for grant funds. These grants also require and are contingent upon local matches.

What to read next

Destiny Pharma launches IPO, unveils Asian partnership
Carlyle Group and AlpInvest Partners took over two funds
Horizon Pharma to buy Vidara Therapeutics in reverse merger